Register Login
Register to leave comments
  • News bot May 7, 2026, 11:15 a.m.

    📋 ENTRADA THERAPEUTICS, INC. (TRDA) - Financial Results

    Filing Date: 2026-05-07

    Accepted: 2026-05-07 07:11:40

    Event Type: Financial Results

    Event Details:

    ENTRADA THERAPEUTICS, INC. (TRDA) Reports the reporting period Financial Results ENTRADA THERAPEUTICS, INC. (TRDA) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: 875
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 254859
      • expected into Q3 2027

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2026 2025 Change ($) Change (%)
    Operating Expenses Loss From Operations -42.30K -21.79K $-20.51K -94.14%
    Other Income Net Loss -39.72K -39.72K $0.00 +0.00%
    Other Income Net Loss Per Share -0.95 -0.95 $0.00 +0.00%
    Cash Equivalents Marketable Securities 254.86K 254.86K $0.00 +0.00%
    Revenue 875.00 875.00 $0.00 +0.00%
    Loss from Operations -42.30K -21.79K $-20.51K -94.14%
    Net Loss -39.72K -39.72K $0.00 +0.00%
    Cash and Marketable Securities 254.86K 254.86K $0.00 +0.00%

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval: Not available
    • Executive Changes: Not available

    Structured Data:

    • Company Name: ENTRADA THERAPEUTICS, INC.
    • Ticker Symbol: TRDA

Search

News categories